Rising Costs of CGM and Insulin Pumps Threaten Patient Access to Home Medical Equipment in Diabetes Care: AAHomecare Warns

August 17, 2026

AAHomecare (via Facebook) America

Overview

Reports indicate that increasing costs for Continuous Glucose Monitoring (CGM) and insulin pumps are impacting access to diabetes care and home medical equipment. Due to largely stagnant reimbursement rates, Home Medical Equipment (HME) providers face financial pressure, potentially hindering timely patient access to essential medical supplies. This issue highlights a growing economic barrier in chronic disease management.

In Depth

Key Findings

The American Association for Homecare (AAHomecare) has issued a warning that rising costs for diabetes care equipment, including continuous glucose monitoring (CGM) systems and insulin pumps, are severely impeding patients’ ability to access home medical equipment. With reimbursement rates effectively stagnating, Home Medical Equipment (HME) providers are facing increasing financial pressure to continue supplying essential medical devices to patients.

Technical/Clinical Details

In diabetes management, CGM and insulin pumps are indispensable technologies that enable continuous glucose surveillance and precise insulin delivery, thereby improving patients’ quality of life and reducing the risk of complications. However, increasing manufacturing costs, R&D expenditures, and supply chain costs for these advanced technologies are being passed on through product pricing. Meanwhile, reimbursement rates for HME providers by Medicare and other insurance programs have not kept pace with these rising costs. This gap between costs and reimbursement makes it difficult for HME providers to operate profitably and, as a result, some providers may restrict the availability of these devices or exit the market altogether. This increases the risk that economically vulnerable patients and those in remote areas may lose access to necessary CGMs and insulin pumps.

Background & Context

Diabetes management has undergone significant transformation in recent years due to advancements in digital health and wearable devices. CGM and insulin pumps have become essential for the daily care of not only Type 1 but also Type 2 diabetes patients. In the U.S., home-based care is promoted as a more cost-effective alternative to hospital care, but the financial challenges faced by HME providers threaten the sustainability of this model. Stagnant reimbursement rates do not just impact provider profits but can directly affect patient health outcomes. In an era of continuous medical technology advancement, situations where accessibility is limited by economic factors are a significant public health concern.

Strategic Significance & Outlook

AAHomecare is strongly advocating for policymakers, insurers, and industry stakeholders to review reimbursement models and implement support measures to ensure the sustainability of HME providers. Restricted access to CGMs and insulin pumps can lead to an increase in diabetes complications, long-term rises in healthcare costs, and a decrease in patient quality of life. Addressing this issue requires a comprehensive approach that establishes fair reimbursement policies and financially supports the role of HME providers, ensuring that all patients can benefit from technological innovation. This warning suggests that resolving economic barriers to the adoption and spread of advanced medical technologies will be a critical focus of future healthcare policy.

Source: https://www.facebook.com/NCHomeCareandHospice/posts/-rising-costs-are-putting-access-to-diabetes-care-at-riskhome-medical-equipment-/1495526072606484/

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.